Data collected by the GeoSentinel Surveillance Network for 1,415 ill travelers returning from Indian Ocean islands during 1997–2010 were analyzed. Malaria (from Comoros and Madagascar), acute nonparasitic diarrhea, and parasitoses were the most frequently diagnosed infectious diseases. An increase in arboviral diseases reflected the 2005 outbreak of chikungunya fever.
The outbreak of chikungunya fever in Indian Ocean islands (IOI) provides new insights on emerging infections in this geographic region (
GeoSentinel sites are specialized travel clinics providing surveillance data for ill travelers. Detailed methods for recruitment of patients for the GeoSentinel database are described elsewhere (
This study comprised 1,415 ill patients (
| Characteristic | All islands, n = 1,415 | Madagascar, n = 502 | Comoros, n = 444 | Maldives, n = 174 | Mauritius, n = 153 | Seychelles, n = 81 | Réunion Island, n = 39 | >1 Island, n = 22 |
|---|---|---|---|---|---|---|---|---|
| Female sex, %† | 47.8 | 47.2 | 42.3 | 51.7 | 51.6 | 63 | 53.8 | 50 |
| Median age, y (95% CI)† | 36 (19–65) | 33 (20–66) | 39 (18–64) | 34 (6–62) | 37 (15–69) | 39 (24–69) | 33 (14–65) | 32 (23–62) |
| Median travel duration, d (95% CI)† | 29 (7–341) | 30 (8–665) | 41 (12–176) | 14 (5–366) | 14 (6–109) | 14 (7–112) | 19 (2–3270) | 35 (9–416) |
| Reason for travel, %† | ||||||||
| Tourism | 44.5 | 53.8 | 5.6 | 62.6 | 81.0 | 85.2 | 48.7 | 59.1 |
| VFR | 30.8 | 5.2 | 89.4 | 0 | 5.2 | 1.2 | 10.3 | 0.0 |
| Missionary/volunteer/ student/military | 12.9 | 24.7 | 1.4 | 21.9 | 3.3 | 1.2 | 5.1 | 27.3 |
| Business | 10.9 | 15.9 | 1.8 | 15.5 | 10.5 | 11.1 | 30.8 | 9.1 |
| Other | 0.1 | 0.4 | 1.8 | 0 | 0 | 1.2 | 5.1 | 4.5 |
| Pre-travel health advice, %† | 43.3 | 55.2 | 32.2 | 47.1 | 35.9 | 37 | 25.6 | 72.7 |
| Inpatient care, % | 30.0 | 7.2 | 79.3 | 8.0 | 9.2 | 3.7 | 12.8 | 4.5 |
*VFR, visiting friends and relatives. †p<0.01 for the comparison among islands.
Illness patterns varied by place of exposure (
Relative proportion of different diagnoses among 1,415 ill travelers returning from Indian Ocean islands, 1997–2010. The numbers are shown for each diagnosis for all ill travelers returning from each island. Some patients had >1 diagnosis. Malaria:
Arboviral disease diagnoses included 40 cases of chikungunya and 24 cases of dengue. Overall, arboviral diseases accounted for 4.5% of the total diagnoses. Arboviral diseases accounted for 36.0% of diseases acquired by travelers to Réunion Island (vs. 3.6% in non–Réunion Island travelers, p<0.01) and were more frequent in tourists than in nontourists (6.5% vs. 2.9%, p<0.01). Numbers of arboviral diseases showed a sustained increase and peaked in 2006. Dengue was noted only after 2001. Chikungunya cases dramatically increased in 2006 and were sustained at a lower level during 2007–2010, suggesting local transformation from epidemic to endemic phases or better notification of the diagnosis (
Annual occurrence of arboviral disease cases (dengue and chikungunya) among 1,415 travelers returning from Indian Ocean islands and seen at GeoSentinel sites, 1997–2010.
Parasitic infections other than malaria accounted for 131 (9.3%) diagnoses. A higher proportion of parasitoses occurred in travelers to Madagascar than in persons who had not traveled there (21.3% vs. 2.6%, p<0.01) and in missionary than non-missionary travelers (18.7% vs. 7.9%, p<0.01). Intestinal helminths or protozoans were the most commonly identified parasites. Schistosomiasis (21 cases) was reported from Madagascar only.
Acute nonparasitic diarrhea accounted for 162 (11.5%) final diagnoses. Higher proportions of such diarrhea occurred in travelers to Madagascar than in persons who had not traveled there (15.7% vs. 9.1%, p<0.01) and in travelers to Maldives than in persons who had not traveled there (18.4% vs. 10.5%, p<0.01). In 23 (14.2%) cases, a pathogen was identified. Acute nonparasitic diarrhea and skin infections were more frequently reported in tourists than in nontourists (17.3% and 12.4% vs. 6.8% and 3.8%, respectively [p<0.01]). The proportion of respiratory infections was higher in persons traveling for business than in persons traveling for other reasons (11.2% vs. 5.1%, p<0.01).
Mosquito bites, food and water consumption, and direct contact with skin were the most frequent modes of disease transmission (
| Mode of transmission | Total no. (%), n = 1,415 | Island visited, no. (%) travelers | ||||||
|---|---|---|---|---|---|---|---|---|
| Madagascar, n = 502 | Comoros, n = 444 | Maldives, n = 174 | Mauritius, n = 153 | Seychelles, n = 81 | Réunion Island, n = 39 | >1 Island, n = 22 | ||
| Mosquito bite | 452 (31.9) | 48 (9.6) | 356 (80.2) | 17 (9.8) | 13 (8.5) | 4 (4.9) | 14 (35.9) | 0 (0.0) |
| Food/water consumption | 236 (16.7) | 138 (27.5) | 10 (2.3) | 40 (23.0) | 27 (17.6) | 20 (24.7) | 3 (7.7) | 2 (9.1) |
| Direct skin contact | 159 (11.2) | 91 (18.1) | 9 (2.0) | 20 (11.5) | 24 (15.7) | 17 (21.0) | 0 | 2 (9.1) |
| Respiratory droplet | 102 (7.2) | 33 (6.6) | 25 (5.6) | 20 (11.5) | 15 (9.8) | 7 (8.6) | 8 (20.5) | 4 (18.2) |
| Animal contact | 44 (3.1) | 15 (3.0) | 0 | 7 (4.0) | 10 (6.5) | 12 (14.8) | 1 (2.6) | 1 (4.5) |
| Fresh water contact | 23 (1.6) | 21 (4.2) | 0 | 0 | 1 (0.7) | 0 | 1 (2.6) | 0 |
| Sex/blood | 7 (0.5) | 3 (0.6) | 1 (0.2) | 1 (0.6) | 0 | 1 (1.2) | 1 (2.6) | 0 |
| Tick bite | 3 (0.2) | 1 (0.2) | 1 (0.2) | 0 | 1 (0.7) | 0 | 0 | 0 |
This large study addresses travel-associated diseases in travelers returning from IOI.
The reports of dengue and chikungunya fever from all islands reflect the wide distribution of the vector,
Parasitic infections, including schistosomiasis, accounted for a major proportion of final diagnoses in travelers to Madagascar, where these infections represent a public health concern (
Nonparasitic diarrhea was reported mainly in tourists returning from Madagascar and the Maldives. Few pathogens were documented, reflecting the practice of empiric antimicrobial treatment before laboratory testing (
Business travelers had a higher proportion of respiratory diseases, independent of the island visited. This finding may relate to longer stays in air conditioned hotels and close human-to-human contact in this population.
These data have at least 4 limitations. First, we included only returning travelers who were ill and receiving care at GeoSentinel sites. Second, self-limited diseases or diseases of short duration may be underrepresented. Third, the lack of a denominator does not permit calculation of prevalence. Fourth, diseases with very short or very long incubation periods might not, with certainty, be attributed to any particular destination. Nevertheless, our study describes the spectrum of diseases among travelers returning from each IOI based on robust numbers of ill travelers.
Ill travelers returning from IOI are heterogeneous in their demographic and travel characteristics and display specific diseases that depend on the island and the travel reason. These findings reflect the different economic, ecologic, and public health situations found across this region (
Geographic, political, economic, and health characteristics of Indian Ocean islands, 1997–2010.
Additional members of the GeoSentinel Surveillance Network who contributed data are listed at the end of this article.
We thank P. Parola who initiated the project. We are also grateful to A. Plier, D. Freedman, the GeoSentinel Surveillance Network staff, special advisors, and the members of the data use and publication committee for helpful comments.
GeoSentinel (
Additional members of the GeoSentinel Surveillance Network who contributed data (in descending order) are as follows: Philippe Parola and Jean Delmont, University Hospital Institute Méditerranée Infection, Marseille, France; François Chappuis, University of Geneva, Geneva, Switzerland; Prativa Pandey and Holly Murphy, CIWEC Clinic Travel Medicine Center, Kathmandu, Nepal; Eric Caumes and Alice Pérignon, Hôpital Pitié-Salpêtrière, Paris, France; Gerd-Dieter Burchard, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany; Michael D. Libman, Brian Ward, and J. Dick Maclean, McGill University, Montreal, Quebec, Canada; Jay S. Keystone and Kevin Kain, University of Toronto, Toronto, Ontario, Canada; Karin Leder, Joseph Torresi, and Graham Brown, Royal Melbourne Hospital, Melbourne, Victoria, Australia; DeVon C. Hale, Rahul Anand, and Stephanie S. Gelman, University of Utah, Salt Lake City, Utah, USA; Shuzo Kanagawa, Yasuyuki Kato, and Yasutaka Mizunno, International Medical Center of Japan, Tokyo, Japan; Phyllis E. Kozarsky, Jessica Fairley, and Carlos Franco-Paredes, Emory University, Atlanta, Georgia, USA; Natsuo Tachikawa, Hanako Kurai, and Hiroko Sagara, Yokohama Municipal Citizen's Hospital, Yokohama, Japan; Sarah Borwein, TravelSafe Medical Centre, Hong Kong, China; Bradley A. Connor, Cornell University, New York, New York, USA; Patricia Schlagenhauf, Rainer Weber, and Robert Steffen, University of Zürich, Zürich, Switzerland; Giampiero Carosi, University of Brescia, Brescia, Italy; Eli Schwartz, Chaim Sheba Medical Center, Tel Hashomer, Israel; Effrossyni Gkrania-Klotsas, Addenbrooke's Hospital, Cambridge, UK; Mogens Jensenius, Oslo University Hospital, Oslo, Norway; Peter de Vries and Kartini Gadroen, University of Amsterdam, Amsterdam, the Netherlands; Watcharapong Piyaphanee and Udomsak Silachamroon, Mahidol University, Bangkok, Thailand; Marc Mendelson and Peter Vincent, University of Cape Town and Tokai Medicross Travel Clinic, Cape Town, South Africa; N. Jean Haulman, David Roesel, and Elaine C. Jong, University of Washington and Harborview Medical Center, Seattle, Washington, USA; Robert Kass, Travellers Medical and Vaccination Centres of Australia, Adelaide, South Australia, Australia (December 1997–March 2001 only); Noreen A. Hynes, R. Bradley Sack, and Robin McKenzie, Johns Hopkins University, Baltimore, Maryland, USA; Alejandra Gurtman, Mount Sinai Medical Center, New York (October 2002–August 2005 only); Christophe Rapp and Olivier Aoun, Hôpital d'instruction des armées Bégin, Saint Mandé, France; Robert Muller, Travel Clinic Services, Johannesburg, South Africa (May 2004–June 2005 only); Thomas B. Nutman and Amy D. Klion, National Institutes of Health, Bethesda, Maryland, USA; Jose Antonio Perez Molina, Ramón y Cajal Hospital, Madrid, Spain; Lin H. Chen and Mary E. Wilson, Mount Auburn Hospital, Harvard University, Cambridge, Massachusetts, USA; Nicole Anderson, Trish Batchelor, and Dominique Meisch, International SOS Clinic, Ho Chi Minh City, Vietnam; William M. Stauffer and Patricia F. Walker, University of Minnesota, Minneapolis, Minnesota, USA; Carmelo Licitra and Antonio Crespo, Orlando Regional Health Center, Orlando, Florida, USA; Annelies Wilder-Smith, Tan Tock Seng Hospital, Singapore; Annemarie Hern, Worldwise Travellers Health and Vaccination Centre, Auckland, New Zealand; Andy Wang, Jane Eason, and Susan MacDonald, Beijing United Family Hospital and Clinics, Beijing, China; Anne McCarthy, University of Ottawa, Ottawa, Ontario, Canada; John D. Cahill and George McKinley, St. Luke’s-Roosevelt Hospital Center, New York; Patrick Doyle and Wayne Ghesquiere, Vancouver General Hospital and Vancouver Island Health Authority, Vancouver and Victoria, British Columbia, Canada; Elizabeth D. Barnett, Boston University, Boston, Massachusetts, USA; Michael W. Lynch, Fresno International Travel Medical Center, Fresno, California, USA (August 2003–February 2010 only); Luis M. Valdez and Hugo Siu, Clínica Anglo Americana, Lima, Peru; and Susan McLellan; Tulane University, New Orleans, Louisiana, USA (December 1999–August 2005 only).
Dr Savini is practitioner in the unit of infectious and tropical disease in the Department of Infectious Diseases, Laveran Military Teaching Hospital, Marseille, France. Her research interests include travel medicine, notably imported malaria.